Report
EUR 13.24 For Business Accounts Only

Thanks to a better fundamental star rating, CURALEAF HOLDING sees an upgrade to Neutral

The independent financial analyst theScreener just awarded an improved star rating to CURALEAF HOLDING (CA), active in the Pharmaceuticals industry. As regards its fundamental valuation, the title receives an improved star rating and now shows 3 out of 4 possible stars. With regard to its market behaviour, it remains unchanged and can be qualified as risky. theScreener considers that these elements allow slightly upgrading its rating to Neutral. As of the analysis date April 1, 2022, the closing price was CAD 8.95 and its expected value was estimated at CAD 8.73.
Underlying
Curaleaf Holdings

Curaleaf Holdings Inc Formerly known as Curaleaf Holdings Inc. Curaleaf Holdings Inc, formerly known as Lead Ventures Inc, is a Canada-based vertically integrated cannabis operator in the United States. The Company is focused on research and development capabilities to distribute cannabis products. The Company operates in 14 states with 53 dispensaries, 15 cultivation sites and 24 processing sites. It provides service, selection, and accessibility across the medical and adult-use markets, as well as the cannabidiol (CBD) category through its Curaleaf Hemp brand. It owns and operates a number of dispensaries, cultivation sites and processing sites with a focus on limited license states, including Florida, Massachusetts, New Jersey and New York.

Provider
TheScreener
TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals.  Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

  • Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization.  theScreener state of art: We provide
  • theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
  • For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded

 

Other Reports on these Companies
Other Reports from TheScreener

ResearchPool Subscriptions

Get the most out of your insights

Get in touch